Nuvectis Pharma Inc. (NVCT)

6.39

-0.30 (-4.48%)

At close: Mar 03, 2025, 11:36 AM

Nuvectis Pharma Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-19M	-22.26M	-19.09M	-12.89M	-24K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	4.86M	4.71M	1.71M	1.89M	n/a
Other Working Capital	2.17M	1.88M	-321K	-91K	10K
Other Non-Cash Items	n/a	-139K	-2.43M	307K	24K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	1.9M	1.74M	3.82M	1.49M	10K
Operating Cash Flow	-12.25M	-15.95M	-13.56M	-9.5M	24K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-382K	9.8M	-4.07M	15.25M	n/a
Financial Cash Flow	11.65M	15.09M	27.81M	15.25M	n/a
Net Cash Flow	-593K	-867K	14.25M	5.74M	24K
Free Cash Flow	-12.25M	-15.95M	-13.56M	-9.5M	24K